Home Digestive Disorders IBD: Ulcerative Colitis What’s Health Canada Saying about Biosimilars?

IBD: Ulcerative Colitis

What’s Health Canada Saying about Biosimilars?

Tags: ,

A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!

This video was made possible by an unrestricted educational grant by Pfizer Canada. 

Related Articles

Tests and Treatment

Tags: ,

Testing for Ulcerative Colitis Often, symptoms alone can provide doctors with the information they need to diagnose ulcerative colitis. Your doctor will perform a physical examination […]

Read More

What is Crohn’s Disease?

Tags:

Inflammatory bowel disease (IBD) is at least two, separate disorders that cause inflammation (redness and swelling) and ulceration (sores) of the small and large intestines. These […]

Read More

Let’s #ImagineUC Differently

Tags:

It’s #IBDAwarenessMonth, and to mark the occasion, Effie, Katie and Emma are sharing their advice for Canadians living with #ulcerativecolitis. Here’s how you can live your […]

Read More

What’s Health Canada Saying about Biosimilars?

https://www.youtube.com/watch?v=1OeDtXWn3_8
A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!